The Wall Street Journal: Nestlé to buy Valeant skin-care rights for $1.4 billion

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 27 May, 2014 by The TZ Newswire Staff

The Wall Street Journal: Nestlé to buy Valeant skin-care rights for $1.4 billion

The move by Nestle, which covers Valeant’s Restylane, Perlane and Emervel products, will bolster the Swiss food giant’s newly established dermatology unit.
read more

See also
- Next Article Matthew Lynn’s London Eye: Europe bubble grows as markets ignore vote against euro
- Previous Article Sterling undervalued, BoE will hike rates in 2014: Pro
Editorial Calender

May 2014

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31

« Jun Jun »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 27 May, 2014 by The TZ Newswire Staff

The Wall Street Journal: Nestlé to buy Valeant skin-care rights for $1.4 billion

See also

Editorial Calender

Recent Tags